These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 10694614)
1. Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease. Starnes SL; Duncan BW; Kneebone JM; Rosenthal GL; Jones TK; Grifka RG; Cecchin F; Owens DJ; Fearneyhough C; Lupinetti FM J Thorac Cardiovasc Surg; 2000 Mar; 119(3):534-9. PubMed ID: 10694614 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor in children with congenital heart disease. Ootaki Y; Yamaguchi M; Yoshimura N; Oka S; Yoshida M; Hasegawa T Ann Thorac Surg; 2003 May; 75(5):1523-6. PubMed ID: 12735573 [TBL] [Abstract][Full Text] [Related]
3. Angiogenic growth factors in patients with cyanotic congenital heart disease and in normal children. Himeno W Kurume Med J; 2001; 48(2):111-6. PubMed ID: 11501491 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor in children with cyanotic and acyanotic and congenital heart disease. Baghdady Y; Hussein Y; Shehata M Arch Med Sci; 2010 Apr; 6(2):221-5. PubMed ID: 22371751 [TBL] [Abstract][Full Text] [Related]
5. Correlation between vascular endothelial growth factor and leptin in children with cyanotic congenital heart disease. Aydin HI; Yozgat Y; Demirkaya E; Olgun A; Okutan V; Lenk MK; Ozcan O Turk J Pediatr; 2007; 49(4):360-4. PubMed ID: 18246735 [TBL] [Abstract][Full Text] [Related]
6. Serum and pulmonary vascular endothelial growth factor/receptors and haemodynamic measurements in cyanotic congenital heart disease with decreased pulmonary blood flow. Tolunay I; Tunaoglu S; Akyürek N; Halid V; Olgunturk R; Kula S Cardiol Young; 2011 Dec; 21(6):608-15. PubMed ID: 21774842 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi. Waltham M; Burnand KG; Collins M; Smith A J Vasc Surg; 2000 Nov; 32(5):988-96. PubMed ID: 11054231 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and its soluble receptor in infants with congenital cardiac disease. Pohl-Schickinger A; Koehne P; Schmitz T; Schmitt KR; Hübler M; Redlin M; Berger F; Stiller B Cardiol Young; 2010 Oct; 20(5):505-8. PubMed ID: 20470449 [TBL] [Abstract][Full Text] [Related]
9. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314 [TBL] [Abstract][Full Text] [Related]
10. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Dirix LY; Vermeulen PB; Pawinski A; Prové A; Benoy I; De Pooter C; Martin M; Van Oosterom AT Br J Cancer; 1997; 76(2):238-43. PubMed ID: 9231925 [TBL] [Abstract][Full Text] [Related]
11. Quantification of angiogenesis stimulators in children with solid malignancies. Pavlakovic H; Von Schütz V; Rössler J; Koscielniak E; Havers W; Schweigerer L Int J Cancer; 2001 Jun; 92(5):756-60. PubMed ID: 11340583 [TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776 [TBL] [Abstract][Full Text] [Related]